NCT00239278: Budesonide / Formoterol in Treatment of Exacerbations of COPD |
|
|
| Completed | 2 | 120 | Europe | budesonide/formoterol, 2x 200/6 microgram. 4 times daily, Symbicort, prednisolone, 30 mg once daily and placebo | AstraZeneca | Chronic Obstructive Pulmonary Disease | | 01/05 | | |
NCT00213252: Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma |
|
|
| Completed | 2 | 130 | Canada | Montelukast plus prednisolone, Prednisolone | The Hospital for Sick Children, Merck Frosst Canada Ltd. | Asthma, Bronchial | 02/08 | 02/08 | | |
